Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults
Status:
Completed
Trial end date:
2019-12-14
Target enrollment:
Participant gender:
Summary
This is a prospective, phase 3, randomized, multicenter, double-blind, double-dummy study to
compare the efficacy and safety of sulopenem followed by sulopenem-etzadroxil/probenecid
versus ertapenem followed by ciprofloxacin for the treatment of complicated urinary tract
infections (cUTI) in adults.
Phase:
Phase 3
Details
Lead Sponsor:
Iterum Therapeutics, International Limited Iterum Therapeutics, US Limited